Article
MET receptor sequence variants R970C and T992I lack transforming capacity.
Cancer research - 1 Aug 2010
Tyner Jeffrey W, Fletcher Luke B, Wang Ellen Q, Yang Wayne F, Rutenberg-Schoenberg Michael L, Beadling Carol, Mori Motomi, Heinrich Michael C, Deininger Michael W, Druker Brian J, Loriaux Marc M
Abstract excerpt
High-throughput sequencing promises to accelerate the discovery of sequence variants, but distinguishing oncogenic mutations from irrelevant "passenger" mutations remains a major challenge. Here we present an analysis of two sequence variants of the MET receptor (hepatocyte growth factor receptor) R970C and T992I (also designated R988C and T1010I). Previous reports indicated that these sequence variants are...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
